Targeting specific RNA molecules in immune cells to treat brain tumors
Macrophage-targeted lncRNA-regulating nanoparticles for glioblastoma treatment
This study is looking at how specific molecules in immune cells might help brain cancer grow, and it aims to create tiny particles that can target these molecules to slow down the cancer and help patients feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10932887 on NIH RePORTER |
What this research studies
This research investigates how certain long non-coding RNAs (lncRNAs) in immune cells called macrophages contribute to the progression of glioblastoma, a type of brain cancer. The team aims to develop nanoparticles that can specifically target these lncRNAs to inhibit tumor growth and improve patient outcomes. By analyzing RNA from both tumor tissue and blood samples, they will identify which lncRNAs are involved in immune suppression related to glioblastoma. This approach could lead to new immune-based therapies for patients with this aggressive cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who may benefit from novel therapeutic approaches targeting immune suppression.
Not a fit: Patients with other types of brain tumors or those who do not have glioblastoma may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for glioblastoma, potentially improving survival rates and quality of life for patients.
How similar studies have performed: While targeting lncRNAs with nanoparticles is a relatively novel approach, there is emerging evidence suggesting that similar strategies have shown promise in other cancer types.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Nduom, Edjah — Emory University
- Study coordinator: Nduom, Edjah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.